Canada - English - Health Canada

seqirus uk limited - haemagglutinin-strain a (h5n1) - suspension - 7.5mcg - haemagglutinin-strain a (h5n1) 7.5mcg - vaccines

Canada - English - Health Canada

seqirus uk limited - haemagglutinin-strain a (h5n1) - suspension - 7.5mcg - haemagglutinin-strain a (h5n1) 7.5mcg - vaccines

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - purified antigen fractions of inactivated split virions - a/indonesia/05/2005 (h5n1)/pr8-ibcdc-rg2 - injection, emulsion - 3.75 µg haemagglutinin/0.25 ml - purified antigen fractions of inactivated split virions - a/indonesia/05/2005 (h5n1)/pr8-ibcdc-rg2 3.75 µg haemagglutinin/0.25 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

csl limited - influenza virus haemagglutinin -

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) - suspension for injection - 30 mcg/0.5ml - active: influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) excipient: aluminium as aluminium phosphate adjuvant calcium chloride dibasic sodium phosphate monobasic potassium phosphate monobasic sodium phosphate potassium chloride sodium chloride thiomersal water for injection - prophylaxis of influenza in an officially declared pandemic situation. the vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the new zealand influenza pandemic action plan.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram - injection, suspension - excipient ingredients: aluminium; dibasic sodium phosphate; calcium chloride dihydrate; potassium chloride; thiomersal; monobasic sodium phosphate; monobasic potassium phosphate; sodium chloride - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with australian health authorities' recommendations, taking into account the recommendation of the world health organisation.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) - suspension for injection - 30 mcg/0.5ml - active: influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) excipient: aluminium as aluminium phosphate adjuvant calcium chloride dibasic sodium phosphate monobasic potassium phosphate monobasic sodium phosphate potassium chloride sodium chloride thiomersal water for injection - prophylaxis of influenza in an officially declared pandemic situation. the vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the new zealand influenza pandemic action plan.

Singapore - English - HSA (Health Sciences Authority)

unison collaborative pte. ltd. - microbiology - the bioline™ influenza ag a/b/a (h1n1) pandemic test kit is a chromatographic immunoassay for the differential and qualitative detection of influenza virus a, b and a(h1n1) antigens directly from nasal/throat/nasopharyngeal swab or nasal/nasopharyngeal aspirate specimens. this assay is intended for professional use and for in vitro diagnostic use only.

European Union - English - EMA (European Medicines Agency)

idt biologika gmbh - inactivated influenza a virus/human - immunologicals, inactivated viral vaccines for pigs, porcine influenza virus - pigs - active immunisation of pigs from the age of 8 weeks onwards against pandemic h1n1 porcine influenza virus to reduce viral lung load and viral excretion.

Canada - English - Health Canada

sanofi pasteur limited - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b (victoria); haemagglutinin-strain b (yamagata) - suspension - 7.5mcg; 7.5mcg; 7.5mcg; 7.5mcg - haemagglutinin-strain a (h1n1) 7.5mcg; haemagglutinin-strain a (h3n2) 7.5mcg; haemagglutinin-strain b (victoria) 7.5mcg; haemagglutinin-strain b (yamagata) 7.5mcg - vaccines